| Category : |
Intermediates/Pharmaceutical intermediates |
 |
| CAS NO : |
115007-34-6 |
| EC NO : |
|
| MF : |
C23H31NO7 |
| MW : |
433.4947 |
| Specification : |
USP42 |
| Packing : |
10 kg/bag; It can also be packed according to the requirements |
| Uses : |
Mycophenolate is used for the prevention of organ transplant rejection. Mycophenolate mofetil is indicated for the prevention of organ transplant rejection in adults and kidney transplantation rejection in children over 2 years; whereas mycophenolate sodi |
| Synonyms : |
4-HEXENOIC ACID,6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-,2-(4-MORPHOLINYL)ETHYL ESTER;MMF;2-Morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate;Mycophenolate Mofetil(MMF);6-[(7-hydroxy-5-methoxy-4-methyl-1-oxo-3h-isobenzofuran-6-yl)]-4-methyl-hex-4-enoic acid 2-morpholinoethyl ester;Macophenolate Mofetil;MycophenolicAcid-2-(4-Morpholinyl)ethylEster;Mycophenolate;2-(morpholin-4-yl)ethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate;Mycophenelate Mofetil; |
| Molecular Structure : |
 |